US warns against use of fluoroquinolones for uncomplicated infectionsBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2755 (Published 16 May 2016) Cite this as: BMJ 2016;353:i2755
- Michael McCarthy
The risk of the serious side effects associated with fluoroquinolone antibiotics outweighs their benefits for the treatment of sinusitis, bronchitis, and uncomplicated urinary tract infections, the US Food and Drug Administration (FDA) said in an advisory issued …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial